SCI Ventures
Venture capitalLondon · Seed–Series B · 18 people tracked
Investment thesis
SCI Ventures is a dedicated venture fund focused on accelerating cures and treatments for paralysis, starting with spinal-cord injury and related markets. Backed by leading paralysis research foundations and clinical centers, the fund brings together investors, entrepreneurs, clinicians and neuroscientists. It invests globally in early-stage companies — typically Seed through Series B — that are built around rigorous, innovative scientific advancements with the greatest potential to impact people living with spinal cord injury. Its aim is to move therapies from the lab to the clinic faster, catalyzing both symptomatic and curative treatments for neurological conditions.
Source: firm website, verified Aug 3, 2026.
Team · 18 people
from the firm's website & public directoriesFounder mafia
3 people who came through SCI Ventures went on to found or lead other companies.
What they invest in
from 4 of 12 portfolio companiesBiotech ×3Healthtech ×3Deep Tech ×2AI & Machine Learning ×1Digital Health ×1Medical Devices ×1
HQs:United States×2United Kingdom×1
Investments · 12 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 12 dated
NervGen is a clinical-stage biotech company developing therapies for neurological conditions, with a focus on spinal cord injury and neurorepair.
BiotechDeep TechHealthtechMedical Devices
Dr. Jerry SilverHarold Punnett(Co-founder)inJerry Silver(Co-founder)William Adams(Executive Officer)Paul Brennan(Director, Executive Officer)Daniel Mikol(Executive Officer)
Co-investorsCWRU Technology Ventures
Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.
BiotechDeep TechBoston, US
Shane Hegarty(Executive Officer)Shane V. Hegarty(Chief Scientific Officer & Co-Founder)Jeffrey Imbaro(Executive Officer)Joanna Stanicka(Chief Executive Officer, President & Co-Founder)inJeff Imbaro(Chief Operating Officer)Tiasha Shafiq(Chief of Staff)
Co-investorsvenBio PartnersMRL Ventures FundSofinnova VenturesCivilization Ventures Management, LlcCreative Destruction Lab (CDL)Hatteras Venture Partners+7 more
Developing targeted gene therapy platform for specific neuronal populations, with initial focus on neurogenic detrusor overactivity in spinal cord injury and neurodegenerative diseases.
Healx is an AI-powered biotech company that discovers and develops treatments for rare diseases.
AI & Machine LearningBiotechDigital HealthHealthtechCambridge, GB
Tim Guilliams(Co-founder & CEO)in
Co-investorsAmadeus Capital PartnersBalderton CapitalCambridge Angels groupIntel Capital
Leader in spinal cord stimulation technology using targeted programmed stimulation to restore movement and function, with first FDA approval expected in 2024.
HealthtechNew York, US
Benjamin Rapoport(President, Chief Science Officer)Michael Mager(Chief Executive Officer)Craig Mermel(President and Chief Product Officer)MIchael Kaswan(Chief Financial Officer)
BoardEric M. Attias(Director)Howard Morgan(Director)in
Co-investorsAlumni VenturesB Capital GroupBasecamp FundForepont Capital PartnersSteadview Capital
Exits · 1
IPOs and acquisitions across the tracked portfolioNervGen PharmaNASDAQ: NGEN
Portfolio news
latest coverage across their companiesPrecision Neuroscience · trysignalbase.com · Mar 9, 2026
Frequently asked questions
- How many investments has SCI Ventures made?
- SCI Ventures has 13 tracked investments, including 2 dated in the last 24 months.
- What stage does SCI Ventures invest at?
- SCI Ventures invests at the Seed, Series A, Series B stages.
- What sectors does SCI Ventures focus on?
- SCI Ventures focuses on Biotech, Deep Tech, Healthtech, Impact & Social Good, Medical Devices.
- Where is SCI Ventures located?
- SCI Ventures is headquartered in London, GB.
- Who does SCI Ventures co-invest with?
- SCI Ventures most often shares deals with Amadeus Capital Partners, B Capital Group, Balderton Capital, among 28 tracked co-investors.
Images
Similar investors
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.
Asabys Partners is a healthcare and life sciences venture capital firm that invests in innovative science and medical technologies to improve patients' lives.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Serendipity Impact VC is an early-stage venture firm backing founders building breakthrough technologies focused exclusively on mental and neuro health.






















